Saponin-Rich Extracts and Their Acid Hydrolysates Differentially Target Colorectal Cancer Metabolism in the Frame of Precision Nutrition

Cancers
Marta Gómez de CedrónAna Ramírez de Molina

Abstract

Saponins or their aglycone form, sapogenin, have recently gained interest as bioactive agents due to their biological activities, their antitumoral effects being among them. Metabolic reprogramming has been recognized as a hallmark of cancer and, together with the increased aerobic glycolysis and glutaminolysis, the altered lipid metabolism is considered crucial to support cancer initiation and progression. The purpose of this study was to assess and compare the inhibitory effects on colorectal cancer cell lines of saponin-rich extracts from fenugreek and quinoa (FE and QE, respectively) and their hydrolyzed extracts as sapogenin-rich extracts (HFE and HQE, respectively). By mean of the latest technology in the analysis of cell bioenergetics, we demonstrate that FE and HFE diminished mitochondrial oxidative phosphorylation and aerobic glycolysis; meanwhile, quinoa extracts did not show relevant activities. Distinct molecular mechanisms were identified for fenugreek: FE inhibited the expression of TYMS1 and TK1, synergizing with the chemotherapeutic drug 5-fluorouracil (5-FU); meanwhile, HFE inhibited lipid metabolism targets, leading to diminished intracellular lipid content. The relevance of considering the coexisting compound...Continue Reading

References

Jun 5, 1991·Journal of the National Cancer Institute·A MonksA Vaigro-Wolff
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 3, 2004·Nature Reviews. Cancer·Eugenia E Calle, Rudolf Kaaks
Nov 30, 2006·Current Opinion in Gastroenterology·Robert S ChapkinJoanne R Lupton
Apr 25, 2007·Critical Reviews in Food Science and Nutrition·Ozlem Güçlü-Ustündağ, Giuseppe Mazza
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 6, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Margarita González-VallinasAna Ramírez de Molina
Jun 10, 2015·Journal of Zhejiang University. Science. B·Xin-ping LiangYing-hua Shi
Aug 9, 2015·Chinese Journal of Natural Medicines·Yan ChenBo-Yang Yu
May 20, 2016·Cancer Research·Omer F KuzuGavin P Robertson
Oct 25, 2016·Antioxidants·Aleksandra S KristoAngelos K Sikalidis
Nov 12, 2016·International Journal of Molecular Sciences·Rocio de la IglesiaAna Ramirez de Molina
Mar 17, 2017·International Journal of Molecular Sciences·Lovro ŽibernaSeyed Mohammad Nabavi
Apr 13, 2017·Molecular Cancer·Xiangjian LuoYa Cao
May 23, 2017·Food Chemistry·Balwinder SinghAmritpal Kaur
Nov 17, 2017·Endocrine, Metabolic & Immune Disorders Drug Targets·Rosa CasasEmilio Sacanella
Jun 2, 2018·Scientific Reports·Lara P FernándezAna Ramírez de Molina
Mar 3, 2019·Breast Cancer Research : BCR·Laura Garcia-Estevez, Gema Moreno-Bueno
Jul 18, 2019·Immunity·Florian R Greten, Sergei I Grivennikov
Sep 24, 2019·Journal of Agricultural and Food Chemistry·Carolina E StornioloJuan J Moreno
Nov 19, 2019·Trends in Cancer·Barrie Peck, Almut Schulze
Dec 17, 2019·Journal of Agricultural and Food Chemistry·Joaquín Navarro Del HierroDiana Martin

❮ Previous
Next ❯

Software Mentioned

Calcusyn
Graph Pad Prism
ColoLipidGene
GraphPad

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.